ARTICLE | Company News
Management tracks
July 9, 2016 12:28 AM UTC
Oncology company Lion Biotechnologies Inc. (NASDAQ:LBIO) said CFO Molly Henderson will resign, effective Aug. 16.
Neurology company Ovid Therapeutics Inc. (New York, N.Y.) promoted Yaron Werber to CBO, while remaining CFO, and Dirk Haasner to SVP from VP of global regulatory affairs. ...